Document is current
Any future updates will be listed below
-
Authors
Chakravarty, Debyani https://orcid.org/0000-0001-8629-5732
Solit, David B. https://orcid.org/0000-0002-6614-802X
- License Information
-
More Information
Article History
Accepted: 12 February 2021
First Online: 24 March 2021
Competing interests
: D.B.S. serves on the Scientific Advisory Board for Loxo Oncology at Eli Lilly, Pfizer, Scorpion Therapeutics, BridgeBio and Vividion Therapeutics, owned stock at Loxo Oncology at Eli Lilly and Scorpion Therapeutics, and received honoraria from Illumina and Eli Lilly. D.C. declares no competing interests.
